
Ep. 190: From The Archives: Chris Gessel Looks At Winning Stocks From Past Corrections
Investing With IBD
The RS Line Is Soaring
The price hasn't really kind of captured that mass of our performance, especially once the market turns. That's another tell with a lot of these leaders. Edwards Life Sciences is where it really started to shine. So again, this looks like a completely normal cup with handle that you would see kind of been just maybe a normal correction. But again, it had been ignoring the downtrend in the market for so long that RS line is soaring.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.